Salermide
-
Catalog number1873-25
-
PricePlease ask
-
Size25 mg
-
-
Alternative_nameN-[3-[[(2-hydroxy-1-naphthalenyl)methylene]amino]phenyl]-a-methyl-benzeneacetamide
-
DescriptionCell-permeable. Salermide is an inhibitor of SIRT1 and SIRT2. In vitro, Salermide has a stronger inhibitory effect on SIRT2 than on SIRT1. It induces massive apoptosis in tumor cells through reactivation of proapoptotic genes epigenetically repressed exclusively in cancer cells by SIRT1.
-
CAS Number1105698-15-4
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₂₆H₂₂N₂O₂
-
Molecular Weight394.47
-
Cell PermeableYes
-
Purity≥98%
-
SolubilitiesDMSO (100 mM)
-
HandlingProtect from air and moisture
-
Tag LineA SIRT1 and SIRT2 inhibitor
-
Storage Condition-20°C
-
Shipping Conditiongel pack
-
Shelf Life24 months
-
MDL NumberMFCD12912446
-
PubChem CID42626405
-
SMILESCC(C1=CC=CC=C1)C(=O)NC2=CC=CC(=C2)NC=C3C(=O)C=CC4=CC=CC=C43
-
InChiInChI=1S/C26H22N2O2/c1-18(19-8-3-2-4-9-19)26(30)28-22-12-7-11-21(16-22) 27-17-24-23-13-6-5-10-20(23)14-15-25(24)29/h2-18,27H,1H3,(H,28, 30)/b24-17-
-
InChi KeyUADRPWLRVLBVBC-ULJHMMPZSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameSalermide
-
Alternative nameSalermide
-